Centro de Investigaciones Biológicas Margarita Salas - CSIC

Centro de Investigaciones Biológicas Margarita Salas - CSIC Esta es la página oficial del Centro de Investigaciones Biológicas Margarita Salas (CIB) del CSIC Ver más: https://www.cib.csic.es/es/sobre-nosotros

El Centro de Investigaciones Biológicas (CIB) es uno de los centros de investigación con mayor prestigio y tradición del Consejo Superior de Investigaciones Científicas (CSIC). En este centro desarrollaron sus investigaciones destacadas generaciones de científicos desde su fundación en 1953, y en él se siguen formando las nuevas. En 2019, en homenaje a una de las investigadoras más relevantes, no

solo de la historia de nuestro centro, en el que pasó un total de 13 años, sino de la Biología Molecular en España, el CIB pasó a denominarse Centro de Investigaciones Biológicas Margarita Salas. Actualmente el CIB Margarita Salas está organizado en cuatro departamentos. En ellos se articulan las investigaciones sobre la estructura y organización de la materia viva y sus procesos, así como las tendentes a comprender las bases de la enfermedad y descubrir tratamientos experimentales, y a desarrollar procesos biotecnológicos relacionados con el crecimiento sostenible y la producción agrícola. De esta forma, conjugamos la generación de nuevo conocimiento con el desarrollo de posibles aplicaciones para la solución de problemas actuales y futuros de la sociedad.

 A team led by Dr. Nuria E. Campillo (Centro de Investigaciones Biológicas Margarita Salas - CSIC) has developed a tool ...
21/08/2026



A team led by Dr. Nuria E. Campillo (Centro de Investigaciones Biológicas Margarita Salas - CSIC) has developed a tool based on generative artificial intelligence (AI) capable of designing molecules with therapeutic potential tailored to specific proteins involved in diseases such as Alzheimer’s. The study, published in the Journal of Chemical Information and Modeling and conducted in collaboration with Dr. David Ríos Insua of the Institute of Mathematical Sciences (ICMAT-CSIC) and the company AItenea Biotech, represents a significant advance in the application of AI to the discovery or identification of new drugs.

More info 🔗https://cib.csic.es/news/research/new-generative-artificial-intelligence-model-accelerates-design-drug-candidate

 An international study with the collaboration of Dr. Marian Oliva at the Centro de Investigaciones Biológicas Margarita...
19/08/2026



An international study with the collaboration of Dr. Marian Oliva at the Centro de Investigaciones Biológicas Margarita Salas - CSIC has mapped the deep evolutionary roots of the eukaryotic cytoskeleton, showing that microtubules, the intracellular “railway system” of our cells, emerged before the origin of complex life.

More info 🔗https://www.science.org/doi/10.1126/sciadv.aeh1082

Published in Science Advances, it has uncovered compelling new evidence about how microtubules evolved, demonstrating that proteins from Asgard archaea, the microbial group considered the closest known relatives of eukaryotes, can assemble into genuine mini-microtubules displaying dynamic instability: the stochastic growth-and-collapse behaviour previously considered exclusive to modern microtubules.

This finding suggests that many of the molecular principles underlying the eukaryotic cytoskeleton emerged long before the appearance of the first complex cells. Strikingly, these ancient filaments are inhibited by maytansine, indicating that its binding site was already present in organisms that predate eukaryotic life.

The research consortium combined phylogenetic mapping of these primordial proteins with high-resolution structural analysis of the ancestral filaments and functional characterization of their biochemical properties. The contribution of the CIB group was central to this functional validation, confirming the enzymatic capability required to function as a dynamic biological switch and demonstrating that the maytansine-binding pocket represents an exceptionally ancient and conserved evolutionary hotspot.

“These findings reveal an extraordinary degree of evolutionary conservation,” explains Dr. Marian Oliva, co-author of the study. “The same molecular mechanisms that allow anticancer drugs to recognize and modulate human microtubules today were already present in ancestral tubulins long before the emergence of eukaryotic cells, likely more than a billion years ago. This tells us that some of the key features of the cytoskeleton became established very early in evolution and have remained largely unchanged ever since.”

 A team of researchers led by Prof. Dolores Pérez-Sala at Centro de Investigaciones Biológicas Margarita Salas - CSIC ha...
18/08/2026



A team of researchers led by Prof. Dolores Pérez-Sala at Centro de Investigaciones Biológicas Margarita Salas - CSIC has demonstrated that pH variations modulate the remodeling of the vimentin network induced by oxidants, positioning this protein as a sensor of both the redox state and cellular pH, enabling highly precise spatial and temporal regulation of complex cellular processes.

More info 🔗https://www.cib.csic.es/news/research/cellular-ph-discovered-key-regulator-response-oxidative-stress-and-cell-migration

 *PhD Candidate Sought for Competitive Predoctoral Fellowships in Air Pollution-induced Vascular Dysfunction*The Experim...
18/08/2026



*PhD Candidate Sought for Competitive Predoctoral Fellowships in Air Pollution-induced Vascular Dysfunction*

The Experimental Pharmacology and New Targets in Cardiopulmonary Disorders Group at the Centro de Investigaciones Biológicas Margarita Salas - CSIC is seeking an excellent candidate to prepare applications for competitive predoctoral fellowships, including the FPU 2026 predoctoral fellowship and Fundación “la Caixa” INPhINIT Retaining.

More information 🔗 https://www.cib.csic.es/fellowship/phd-candidate-sought-competitive-predoctoral-fellowships-air-pollution-induced-vascular

This November, the Autumn Online Training School organized by EU-OPENSCREEN returns with three days of expert-led sessio...
17/08/2026

This November, the Autumn Online Training School organized by EU-OPENSCREEN returns with three days of expert-led sessions covering chemical biology and modern advancements in drug discovery.

📅 3–5 November 2026
💻 Online
💶 Participation is free of charge.

This year's program covers:
• Foundations of Drug Discovery
• Data & AI Transforming the Discovery Pipeline
• Global Collaborations
• Funding Opportunities

Participants attending the school will receive an official Certificate of Attendance upon completion.

👉 Register here:
https://lnkd.in/ekDijh5v

👉 For more detailed information, visit:
https://lnkd.in/eMJ7upnx

 An international team of researchers led by Dr. Marian Oliva (Centro de Investigaciones Biológicas Margarita Salas - CS...
17/08/2026



An international team of researchers led by Dr. Marian Oliva (Centro de Investigaciones Biológicas Margarita Salas - CSIC) has uncovered a new principle governing how the widely used anticancer drug Taxol (paclitaxel) affects cells.
Their findings provide a strategy for developing next-generation taxane drugs that retain their therapeutic benefits while potentially reducing the risk of chemotherapy-induced peripheral neuropathy, one of the most common dose-limiting side effects in treatment.

More info 🔗https://www.cib.csic.es/news/research/new-discovery-could-lead-chemotherapy-based-taxanes-fewer-nerve-damaging-side-effects

 The group from the Centro de Investigaciones Biológicas Margarita Salas - CSIC, led by Dr. Carlos Fernández Tornero, in...
29/07/2026



The group from the Centro de Investigaciones Biológicas Margarita Salas - CSIC, led by Dr. Carlos Fernández Tornero, in collaboration with the company PharmaMar, has revealed key structural features of ecteinascidins binding to DNA.

In a study published in the journal , the authors show how these small anticancer molecules of marine origin form covalent bonds and engage in extensive non-covalent interactions with the minor groove of the DNA double helix. These findings provide a structural framework for the design of new anticancer compounds.

More info 🔗https://www.cib.csic.es/news/research/dna-targeting-mechanism-marine-anticancer-drugs-uncovered

cc: CSIC, CSIC Divulga

La presidenta del CSIC, Eloísa del Pino, ha visitado el Centro de Investigaciones Biológicas Margarita Salas - CSIC, aco...
24/07/2026

La presidenta del CSIC, Eloísa del Pino, ha visitado el Centro de Investigaciones Biológicas Margarita Salas - CSIC, acompañada de la vicepresidenta de Innovación y Transferencia, Ana Castro, y del secretario general del organismo, Ignacio Gutiérrez.

Han recorrido las dos nuevas plantas piloto del centro: la de bioprocesos microbianos y analítica y la de diseño de biocatalizadores enzimáticos, financiadas con 2,65 millones de euros del Plan de Recuperación, Transformación y Resiliencia (PRTR) a través del Ministerio de Ciencia, Innovación y Universidades.

🔗https://cib.csic.es/es/news/otros/eloisa-del-pino-presidenta-del-csic-visita-la-planta-piloto-de-bioprocesos-del-cib

 The Centro de Investigaciones Biológicas Margarita Salas - CSIC will host the International Symposium on Ageing, a two-...
23/07/2026



The Centro de Investigaciones Biológicas Margarita Salas - CSIC will host the International Symposium on Ageing, a two-day scientific meeting bringing together internationally renowned experts to discuss the latest advances in ageing research and age-related diseases.

Coordinated by Ana O’Loghlen and Ignacio Benedicto, the symposium will take place in the CIB Auditorium on October 1 and October 7, 2026, from 9:00 a.m. to 1:00 p.m. on both days.

Registration is free (but required) and open to all interested participants.

Registration 🔗https://forms.gle/yY5wFh7srQEvi3zt6
More info 🔗https://www.cib.csic.es/news/research/international-symposium-ageing-bring-world-leading-researchers-cib-margarita-salas

Dirección

Calle Ramiro De Maeztu 9
Madrid
28040

Notificaciones

Sé el primero en enterarse y déjanos enviarle un correo electrónico cuando Centro de Investigaciones Biológicas Margarita Salas - CSIC publique noticias y promociones. Su dirección de correo electrónico no se utilizará para ningún otro fin, y puede darse de baja en cualquier momento.

Compartir